CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 158 enrolled
Drug / intervention
prazosin hydrochloride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02226367
NCT02226367N/ACompleted
CompareCT.gov

Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD

Seattle Institute for Biomedical and Clinical Research·interventional·Posted Aug 27, 2014·Updated Feb 3, 2023

In Brief

A clinical study evaluating prazosin hydrochloride and placebo for Alcohol Use Disorders and 2 related conditions. Completed, enrolled 158 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate if the drug prazosin: * will decrease alcohol use in active duty members of the military who served in Iraq and/or Afghanistan and * determine if presence or absence of posttraumatic stress disorder affects treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorders, Stress Disorders, Posttraumatic, Combat Disorders
CountriesUnited States
CollaboratorsUnited States Department of Defense, VA Puget Sound Health Care System

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 27, 2014
Enrollment StartJan 1, 2015
Primary CompletionSep 20, 2018
Study CompletionOct 20, 2018
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 11.8 years ago

Interventions

prazosin hydrochloridedrug

study drug arm prazosin

placebodrug

study drug arm placebo